Name | Pramiracetam |
Synonyms | ReMen Amacetam PraMistar NeupraMir Vinpotropil Pramiracetam PRAMIRACETAM N-[2-(Diisopropylamino)ethyl]-2-oxo-1-pyrrolidineacetamide N-(2-(Bis(1-methylethyl)amino)ethyl)-2-oxo-1-pyrrolidineacetamide N-[2-(dipropan-2-ylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide |
CAS | 68497-62-1 |
InChI | InChI=1/C14H27N3O2/c1-11(2)17(12(3)4)9-7-15-13(18)10-16-8-5-6-14(16)19/h11-12H,5-10H2,1-4H3,(H,15,18) |
Molecular Formula | C14H27N3O2 |
Molar Mass | 269.38 |
Density | 1.036g/cm3 |
Melting Point | 47-48° |
Boling Point | 461°C at 760 mmHg |
Flash Point | 232.6°C |
Water Solubility | H2O: soluble10mg/mL, clear |
Vapor Presure | 1.11E-08mmHg at 25°C |
Storage Condition | 2-8℃ |
Refractive Index | 1.495 |
Physical and Chemical Properties | Storage conditions Sealed in dry,2-8°C morphology powder acidity coefficient (pKa) 14.76±0.46(Predicted) color white to beige. Merck 14,7706 |
Use | This product is for scientific research only and shall not be used for other purposes. |
Hazard Symbols | Xn - Harmful |
Risk Codes | 22 - Harmful if swallowed |
Pramiracetam (CI-879) is a more effective nootropic drug derived from Piracetam
Alzheimer's disease is a chronic progressive disease characterized by mental decline, obvious changes in behavior and personality, and is accompanied by systemic decline of various tissues and organs, including cerebrovascular Alzheimer's disease, Alzheimer's type dementia, mixed dementia and other types. 50% ~ 70% of them are Alzheimer's disease. In recent years, the incidence of Alzheimer's disease has increased year by year with the aging of the world population. Therefore, the research and development of anti-Alzheimer's drugs have important practical significance.
Placetam is a pyrrolidone brain metabolism improvement drug. It is a central nervous drug that can improve memory and anti-amnesia. It is developed by Parke-Davis Pharmaceutical Company in the United States. It has a strong ability to improve brain function, enhance memory, and promote brain alertness. Clinical experiments have proved that its activity is 6-13 times that of piracetam (Naofekang), 3-4 times that of oxiracetam, and low toxicity, good tolerance, can be used for long-term medication, improve symptoms, delay Alzheimer's dementia.
Clinically applicable to the elderly attention and memory disorders, benign aging forgetfulness, senile dementia disease (Alzheimer's disease) prevention, enhance memory. Placetam is also used in bodybuilding exercises to dilate blood vessels.
N,N-diisopropylethylenediamine is an important intermediate for the preparation of prasetam.
melting point | 47-48° |
boiling point | bp0.15 162-164° |
density | 1.036±0.06 g/cm3(Predicted) |
storage conditions | Sealed in dry,2-8°C |
solubility | H2O: soluble10mg/mL, clear |
morphology | powder |
acidity coefficient (pKa) | 14.76±0.46(Predicted) |
color | white to beige |
Merck | 14,7706 |